Cargando…

Sodium thiosulfate attenuates glial-mediated neuroinflammation in degenerative neurological diseases

BACKGROUND: Sodium thiosulfate (STS) is an industrial chemical which has also been approved for the treatment of certain rare medical conditions. These include cyanide poisoning and calciphylaxis in hemodialysis patients with end-stage kidney disease. Here, we investigated the anti-inflammatory acti...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Moonhee, McGeer, Edith G., McGeer, Patrick L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4746933/
https://www.ncbi.nlm.nih.gov/pubmed/26856696
http://dx.doi.org/10.1186/s12974-016-0488-8
_version_ 1782414897099833344
author Lee, Moonhee
McGeer, Edith G.
McGeer, Patrick L.
author_facet Lee, Moonhee
McGeer, Edith G.
McGeer, Patrick L.
author_sort Lee, Moonhee
collection PubMed
description BACKGROUND: Sodium thiosulfate (STS) is an industrial chemical which has also been approved for the treatment of certain rare medical conditions. These include cyanide poisoning and calciphylaxis in hemodialysis patients with end-stage kidney disease. Here, we investigated the anti-inflammatory activity of STS in our glial-mediated neuroinflammatory model. METHODS: Firstly, we measured glutathione (GSH) and hydrogen sulfide (H(2)S, SH(−)) levels in glial cells after treatment with sodium hydrosulfide (NaSH) or STS. We also measured released levels of tumor necrosis factor-α (TNFα) and interleukin-6 (IL-6) from them. We used two cell viability assays, MTT and lactate dehydrogenase (LDH) release assays, to investigate glial-mediated neurotoxicity and anti-inflammatory effects of NaSH or STS. We also employed Western blot to examine activation of intracellular inflammatory pathways. RESULTS: We found that STS increases H(2)S and GSH expression in human microglia and astrocytes. When human microglia and astrocytes are activated by lipopolysaccharide (LPS)/interferon-γ (IFNγ) or IFNγ, they release materials that are toxic to differentiated SH-SY5Y cells. When the glial cells were treated with NaSH or STS, there was a significant enhancement of neuroprotection. The effect was concentration-dependent and incubation time-dependent. Such treatment reduced the release of TNFα and IL-6 and also attenuated activation of P38 MAPK and NFκB proteins. The compounds tested were not harmful when applied directly to all the cell types. CONCLUSIONS: Although NaSH was somewhat more powerful than STS in these in vitro assays, STS has already been approved as an orally available treatment. STS may therefore be a candidate for treating neurodegenerative disorders that have a prominent neuroinflammatory component. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12974-016-0488-8) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4746933
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-47469332016-02-10 Sodium thiosulfate attenuates glial-mediated neuroinflammation in degenerative neurological diseases Lee, Moonhee McGeer, Edith G. McGeer, Patrick L. J Neuroinflammation Research BACKGROUND: Sodium thiosulfate (STS) is an industrial chemical which has also been approved for the treatment of certain rare medical conditions. These include cyanide poisoning and calciphylaxis in hemodialysis patients with end-stage kidney disease. Here, we investigated the anti-inflammatory activity of STS in our glial-mediated neuroinflammatory model. METHODS: Firstly, we measured glutathione (GSH) and hydrogen sulfide (H(2)S, SH(−)) levels in glial cells after treatment with sodium hydrosulfide (NaSH) or STS. We also measured released levels of tumor necrosis factor-α (TNFα) and interleukin-6 (IL-6) from them. We used two cell viability assays, MTT and lactate dehydrogenase (LDH) release assays, to investigate glial-mediated neurotoxicity and anti-inflammatory effects of NaSH or STS. We also employed Western blot to examine activation of intracellular inflammatory pathways. RESULTS: We found that STS increases H(2)S and GSH expression in human microglia and astrocytes. When human microglia and astrocytes are activated by lipopolysaccharide (LPS)/interferon-γ (IFNγ) or IFNγ, they release materials that are toxic to differentiated SH-SY5Y cells. When the glial cells were treated with NaSH or STS, there was a significant enhancement of neuroprotection. The effect was concentration-dependent and incubation time-dependent. Such treatment reduced the release of TNFα and IL-6 and also attenuated activation of P38 MAPK and NFκB proteins. The compounds tested were not harmful when applied directly to all the cell types. CONCLUSIONS: Although NaSH was somewhat more powerful than STS in these in vitro assays, STS has already been approved as an orally available treatment. STS may therefore be a candidate for treating neurodegenerative disorders that have a prominent neuroinflammatory component. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12974-016-0488-8) contains supplementary material, which is available to authorized users. BioMed Central 2016-02-08 /pmc/articles/PMC4746933/ /pubmed/26856696 http://dx.doi.org/10.1186/s12974-016-0488-8 Text en © Lee et al. 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Lee, Moonhee
McGeer, Edith G.
McGeer, Patrick L.
Sodium thiosulfate attenuates glial-mediated neuroinflammation in degenerative neurological diseases
title Sodium thiosulfate attenuates glial-mediated neuroinflammation in degenerative neurological diseases
title_full Sodium thiosulfate attenuates glial-mediated neuroinflammation in degenerative neurological diseases
title_fullStr Sodium thiosulfate attenuates glial-mediated neuroinflammation in degenerative neurological diseases
title_full_unstemmed Sodium thiosulfate attenuates glial-mediated neuroinflammation in degenerative neurological diseases
title_short Sodium thiosulfate attenuates glial-mediated neuroinflammation in degenerative neurological diseases
title_sort sodium thiosulfate attenuates glial-mediated neuroinflammation in degenerative neurological diseases
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4746933/
https://www.ncbi.nlm.nih.gov/pubmed/26856696
http://dx.doi.org/10.1186/s12974-016-0488-8
work_keys_str_mv AT leemoonhee sodiumthiosulfateattenuatesglialmediatedneuroinflammationindegenerativeneurologicaldiseases
AT mcgeeredithg sodiumthiosulfateattenuatesglialmediatedneuroinflammationindegenerativeneurologicaldiseases
AT mcgeerpatrickl sodiumthiosulfateattenuatesglialmediatedneuroinflammationindegenerativeneurologicaldiseases